Genmab A/S (CPH:GMAB)
Denmark flag Denmark · Delayed Price · Currency is DKK
1,358.00
-5.50 (-0.40%)
Jul 9, 2025, 3:00 PM CET

Genmab Market Cap

Genmab has a market cap or net worth of 83.86 billion as of July 9, 2025. Its market cap has decreased by -27.05% in one year.

Market Cap
83.86B
Enterprise Value
62.58B
Revenue
22.30B
Ranking
n/a
PE Ratio
10.76
Stock Price
1,358.00

Market Cap Chart

Since October 18, 2000, Genmab's market cap has increased from 3.68B to 83.86B, an increase of 2,176.17%. That is a compound annual growth rate of 13.47%.

History

DateMarket Cap% Change
Jul 8, 202583.86B-11.55%
Dec 30, 202494.81B-32.65%
Dec 29, 2023140.77B-26.77%
Dec 30, 2022192.23B11.72%
Dec 30, 2021172.06B6.80%
Dec 30, 2020161.11B67.11%
Dec 30, 2019 Pro Pro
Dec 28, 2018 Pro Pro
Dec 29, 2017 Pro Pro
Dec 30, 2016 Pro Pro
Dec 30, 2015 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Novo Nordisk 1,997.35B
Coloplast 136.59B
Demant 57.00B
ALK-Abelló 42.18B
H. Lundbeck 34.17B
Zealand Pharma 26.62B
Ambu A/S 26.12B
GN Store Nord 14.43B
Market Cap Rankings